Showing results (471-480 of 501) with videos related to
Sort By:
Pageof 51
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2007
Revised response criteria for malignant lymphomaBruce D Cheson, Beate Pfistner, Malik E Juweid, et al.Journal of Hematology & Oncology|June 30, 2018
Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantationRobert W Chen, Joycelynne M Palmer, Sarah Tomassetti, et al.Nature|April 24, 2024
Probing entanglement in a 2D hard-core Bose-Hubbard latticeAmir H Karamlou, Ilan T Rosen, Sarah E Muschinske, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 24, 2024
Nuclear Control of Mitochondrial Homeostasis and Venetoclax Efficacy in AML via COX4I1Leisi Zhang, Honghai Zhang, Ting-Yu Wang, et al.Human Gene Therapy|February 11, 1998
Adoptive immunotherapy for leukemia: donor lymphocytes transduced with the herpes simplex thymidine kinase gene for remission induction. HGTRI 0103C J Link, R K Burt, A E Traynor, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 23, 2017
Long-Term Results of High-Dose Therapy and Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: Effectiveness of Maintenance RituximabMatthew G Mei, Thai M Cao, Lu Chen, et al.The Lancet. Haematology|November 20, 2022
Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trialAlex F Herrera, Lu Chen, Yago Nieto, et al.Journal of Cellular Physiology|February 17, 2019
8-chloro-adenosine activity in FLT3-ITD acute myeloid leukemiaRalf Buettner, Le Xuan Truong Nguyen, Bijender Kumar, et al.Pulmonary Circulation|April 3, 2025
Cellular Communication Network Protein 2 in the Right Ventricle of Pulmonary Arterial HypertensionCarly E Byrd, Jennifer E Schramm, Jun Yang, et al.The Lancet. Oncology|January 17, 2017
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b studyJohn F Seymour, Shuo Ma, Danielle M Brander, et al.Pageof 51